Do oral direct factor Xa inhibitors improve safety and efficacy compared to conventional anticoagulant strategies for primary and secondary prophylaxis in patients with nephrotic syndrome?
Oral direct factor Xa inhibitors may offer a safer and more effective alternative to conventional anticoagulation for primary and secondary prophylaxis in patients with nephrotic syndrome.
This study suggests that DOAC are safer and more effective than conventional anticoagulant strategies for both primary and secondary prophylaxis in patients with NS.
Arches et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: